PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Palbociclib|DRUG: Placebo|DRUG: Tamoxifen|DRUG: Goserelin
Sponsor: National Cancer Center, Japan
Collaborators: Pfizer|Korean Cancer Study Group